Delivery Order SPE2DB22D1106-SPE2DB24FEFT3

Award Date 3/19/24
Potential Completion Date 3/20/24
Potential Value $77K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical distributor. The award is for the supply of GONAL-F RFF REDI-JECT 900 UNIT 1.5ML, a pharmaceutical product, with a potential value of $83,437.62 and a completion date of February 28, 2024. Amerisourcebergen Drug Corp is the sole awardee on this delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $99,353.28 firm fixed-price delivery order is for the supply of GONAL-F RFF REDI-JECT 450 UNIT 0.75ML, a specialty pharmaceutical product. This award is a task order under Amerisourcebergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The award is for the delivery of Gonal-F RFF Redi-Ject 450 unit 0.75ml, a specialty pharmaceutical product. The contract is a firm fixed price delivery order with a ceiling value of $19,900.73 and a period of performance through April 11, 2024. This...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of GONAL-F RFF REDI-JECT 900 UNIT 1.5ML, a pharmaceutical product, with a ceiling value of $136,146.74 and a period of performance through January 16, 2025. The contract is a firm fixed-price delivery order, with no set-aside designation, suggesting open competition....
This is a federal contract award to Amerisourcebergen Drug Corp's Corporate Office division, a major pharmaceutical distribution company, by the Defense Logistics Agency (DLA). The contract is for the delivery of 4,564,437,307 units of the medication "GONAL-F RFF REDI-JECT 900 UNIT 1.5ML" with a ceiling value of $15,276.64. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of April 30, 2024. Amerisourcebergen holds a larger...
This federal contract award, valued at $8,386.53, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of GONAL-F RFF REDI-JECT 900 UNIT 1.5ML, a specialty pharmaceutical product. This award is associated with a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen's parent company, Cencora, Inc., with the DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,181.45 firm fixed-price delivery order is for the supply of GONAL-F RFF REDI-JECT 300 UNIT 0.5ML, a specialty pharmaceutical product. The contract has an ultimate completion date of August 28, 2023. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $10,924.94, is for the delivery of GONAL-F RFF REDI-JECT 450 UNIT 0.75ML medical products. This contract is a delivery order under a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA, valued at $999,999,999 and running through November 2026. The IDC...
This federal contract award is a delivery order (SPE2DB22FL7N3) with a ceiling value of $10,781.10, issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The award is for the supply of GONAL-F RFF REDI-JECT 900 UNIT 1.5ML, a specialty pharmaceutical product, with a period of performance through November 23, 2021. The contract is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen Drug Corp holds with the DLA...
This federal contract award, valued at $9,547.40, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of the pharmaceutical product GONAL-F RFF REDI-JECT 900 UNIT 1.5ML, a critical medication used in various medical treatments. This award is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora,...
  • SPE2DB22D1106
    Indefinite Delivery Contract
  • SPE2DB22D1106-SPE2DB24FEFT3
    Delivery Order

This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation. The $76,965.58 award is for the provision of 4,564,016,451 units of the pharmaceutical product GONAL-F RFF REDI-JECT 900 (1.5 ML). This delivery order falls under a larger indefinite delivery contract (IDC) with a potential value of $999,999,999.00 awarded solely to AmerisourceBergen Drug Corp, which serves as the primary contract vehicle for the company to deliver pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. The delivery order has an ultimate completion date of March 20, 2024. No set-aside designation was used for this award.

Generated 6/18/24, 2:22 PM